Adoptive Immunotherapy with Tregs Prevents GvHD and Favours Immune Reconstitution After HLA Haploidentical Transplants for Hematological Malignancies

被引：13
|
作者：
Di Ianni, Mauro [1 ]
Falzetti, Franca [1 ]
Carotti, Alessandra [1 ]
Terenzi, Adelmo [1 ]
Bonifacio, Elisabetta [1 ]
Reisner, Yair [2 ]
Velardi, Andrea [1 ]
Aversa, Franco [1 ]
Martelli, Massimo F. [1 ]
机构：
[1] Dept Clin & Expt Med, Hematol & Clin Immunol Sect, Perugia, Italy
[2] Weizmann Inst Sci, Dept Immunol, IL-76100 Rehovot, Israel
来源：
BLOOD | 2009年 / 114卷 / 22期
关键词：
D O I：
10.1182/blood.V114.22.4.4
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：4 / 4
页数：1
相关论文
共 50 条
  • [31] IMMUNE RECONSTITUTION AFTER NONMYELOABLATIVE, T-CELL REPLETE, HLA-HAPLOIDENTICAL BMT WITH POST-TRANSPLANTATION CYCLOPHOSPHAMIDE
    Kesserwan, C.
    Munchel, A.
    Kos, F.
    Thoburn, C.
    Hess, A.
    Luznik, L.
    Kasamon, Y.
    Levitsky, H.
    Jones, R.
    Fuchs, E. J.
    Symons, H. J.
    BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2011, 17 (02) : S230 - S231
  • [32] GMP protocol for adoptive immunotherapy with Aspergillus specific T-cells for immune reconstitution after allogenic stem cell transplantation
    Duell, J.
    Khanna, N.
    Lurati, S.
    Rasche, L.
    Einsele, H.
    Topp, M.
    ONKOLOGIE, 2012, 35 : 59 - 59
  • [33] Early Lymphocyte Recovery Predicts Superior Survival after Unmanipulated HLA-Mismatched/Haploidentical Blood and Marrow Transplantation for Patients with Hematological Malignancies
    Chang, Ying jun
    Zhao, Xiang yu
    Huo, Ming rui
    Xu, Lan ping
    Liu, Dai hong
    Liu, Kai yan
    Huang, Xiao Jun
    BLOOD, 2008, 112 (11) : 774 - 774
  • [34] Preventing GvHD and high-risk acute leukemia relapse by Treg and Tcon adoptive immunotherapy in HLA-haploidentical transplantation: an update on the clinical trial and insights from murine studies
    Ruggeri, L.
    Di Ianni, M.
    Falzetti, F.
    Carotti, A.
    Terenzi, A.
    Massei, M. S.
    Amico, L.
    Pierini, A.
    Urbani, E.
    Falini, B.
    Martelli, M. F.
    Velardi, A.
    BONE MARROW TRANSPLANTATION, 2015, 50 : S21 - S21
  • [35] EBV REACTIVATION AND PTLD AFTER ALLO-HSCT. A SINGLE CENTER EXPERIENCE IN T-CELL DEPLETED TRANSPLANTS WITH ADOPTIVE IMMUNOTHERAPY AND IN UNMANIPULATED TRANSPLANTS WITH POST-TRANSPLANT GVHD PROPHYLAXIS
    Viglione, Valerio
    Ruggeri, Loredana
    Pierini, Antonio
    Terenzi, Adelmo
    Tricarico, Sara
    Cipiciani, Alessandra
    Sembenico, Rebecca
    Mariannelli, Mattia
    De Santis, Sara
    Zorutti, Francesco
    Castronari, Roberto
    Bozza, Silvia
    Mecucci, Cristina
    Mencacci, Antonella
    Carotti, Alessandra
    BONE MARROW TRANSPLANTATION, 2023, 58 (SUPP1) : 437 - 438
  • [36] Favorable Immune Reconstitution After Nonmyeloablative, T-Cell Replete, HLA-Haploidentical BMT with Post-Transplant Cyclophosphamide
    Symons, Heather J.
    Kesserwan, Chimene
    Kos, Ferdynand
    Thoburn, Christopher J.
    Munchel, Ashley T.
    Ying, Wendy
    Luznik, Leo
    Levitsky, Hyam I.
    Jones, Richard J.
    Hess, Allan D.
    Fuchs, Ephraim J.
    BLOOD, 2011, 118 (21) : 461 - 462
  • [37] Acute GvHD after HLA- Haploidentical Hematopoietic Cell Transplantation with Regulatory and Conventional T Cell Immunotherapy Does Not Adversely Affect Transplantation Outcomes
    Bonato, Samanta
    Del Sordo, Rachele
    Mancusi, Antonella
    Terenzi, Adelmo
    Zei, Tiziana
    Ostini, Roberta Iacucci
    Tricarico, Sara
    Piccinelli, Sara
    Griselli, Mario
    Marzuttini, Francesca
    Viglione, Valerio
    Torti, Eleonora
    Sembenico, Rebecca
    Limongello, Roberto
    Merluzzi, Mara
    Hoxha, Eni
    Ciardelli, Sara
    Sola, Rosaria
    Falzetti, Franca
    Giansanti, Michele
    Martelli, Massimo Fabrizio
    Ruggeri, Loredana
    Carotti, Alessandra
    Velardi, Andrea
    Pierini, Antonio
    BLOOD, 2021, 138
  • [38] Single-agent GvHD prophylaxis with tacrolimus after post-transplant high-dose cyclophosphamide is a valid option for haploidentical transplantation in adults with hematological malignancies
    Esquirol, A.
    Pascual, M. J.
    Ortiz, M.
    Pinana, J. L.
    Ferra, C.
    Garcia Cadenas, I.
    Vilades, I.
    Brunet, S.
    Martino, R.
    Sierra, J.
    BONE MARROW TRANSPLANTATION, 2017, 52 (09) : 1273 - 1279
  • [39] Single-agent GvHD prophylaxis with tacrolimus after post-transplant high-dose cyclophosphamide is a valid option for haploidentical transplantation in adults with hematological malignancies
    A Esquirol
    M J Pascual
    M Ortiz
    J L Piñana
    C Ferra
    I Garcia Cadenas
    I Vilades
    S Brunet
    R Martino
    J Sierra
    Bone Marrow Transplantation, 2017, 52 : 1273 - 1279
  • [40] Infusion of HSV-Tk engineered donor lymphocytes provide early immune reconstitution and abrogation of GvHD after haploidentical hemopoietic stem cell transplantation.
    Ciceri, F
    Bonini, C
    Bondanza, A
    Magnani, Z
    Bernardi, M
    Peccatori, J
    Crippa, F
    Stampino, CG
    Bregni, M
    Bordignon, C
    Raffaele, HS
    BLOOD CELLS MOLECULES AND DISEASES, 2004, 33 (03) : 180 - 181
12345